Axcelis Technologies, Inc. (ACLS) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts ACLS Hot Sheet
Price: $119.17 +3.55%
Revenue Growth %: +0.5%
Financial Fact:
Total Cost of revenue: 41.55M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +0.5%
Financial Fact:
Total Cost of revenue: 41.55M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Axcelis Technologies, Inc. (NASDAQ: ACLS) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $41.2 million versus the consensus estimate of $40.75 million.
For earnings history and earnings-related data on Axcelis Technologies, Inc. (ACLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
